Johnson & Johnson Completes Acquisition of Shockwave Medical

Go back to Johnson & Johnson Completes Acquisition of Shockwave Medical

Johnson & Johnson (JNJ) ordered to pay $260 million in talc trial - Reuters

June 4, 2024 9:16 AM EDT

According to a report from Reuters on Tuesday, Johnson & Johnson (NYSE: JNJ) must pay $260 million to an Oregon woman who said she developed mesothelioma, a cancer linked to asbestos exposure from inhaling the company's talc powder.

The verdict includes $60 million in compensatory damages and $200 million in... More